These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9765819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Distribution of antigenic glycolipids among Mycobacterium tuberculosis strains and their contribution to virulence].
    Fujiwara N.
    Kekkaku; 1997 Apr; 72(4):193-205. PubMed ID: 9145649
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DOT-ELISA for detection of phenolic glycolipid PGL-Tb1 and diacyl-trehalose antigens of Mycobacterium tuberculosis.
    Papa F, Luquin M, David HL.
    Res Microbiol; 1992 Apr; 143(3):327-31. PubMed ID: 1448617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serological specificity of Mycobacterium tuberculosis glycolipids.
    Papa F, Laszlo A, David HL, Daffé M.
    Acta Leprol; 1989 Apr; 7 Suppl 1():98-101. PubMed ID: 2504016
    [Abstract] [Full Text] [Related]

  • 7. Production of monoclonal antibody to a phenolic glycolipid of Mycobacterium tuberculosis and its use in detection of the antigen in clinical isolates.
    Cho SN, Shin JS, Daffe M, Chong Y, Kim SK, Kim JD.
    J Clin Microbiol; 1992 Dec; 30(12):3065-9. PubMed ID: 1452686
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients.
    Simonney N, Dewulf G, Herrmann JL, Gutierrez MC, Vicaut E, Boutron C, Leportier M, Lafaurie M, Abgrall S, Sereni D, Autran B, Carcelain G, Bourgarit A, Lagrange PH.
    Tuberculosis (Edinb); 2008 Sep; 88(5):453-61. PubMed ID: 18495539
    [Abstract] [Full Text] [Related]

  • 10. Recognition of phenolic glycolipid-I (Mycobacterium leprae) and sulfolipid-I (M. tuberculosis) by serum from Mexican patients with leprosy or tuberculosis.
    Rojas-Espinosa O, Luna-Herrera J, Arce-Paredes P.
    Int J Tuberc Lung Dis; 1999 Dec; 3(12):1106-12. PubMed ID: 10599015
    [Abstract] [Full Text] [Related]

  • 11. Structural elucidation of new phenolic glycolipids from Mycobacterium tuberculosis.
    Watanabe M, Yamada Y, Iguchi K, Minnikin DE.
    Biochim Biophys Acta; 1994 Jan 03; 1210(2):174-80. PubMed ID: 8280767
    [Abstract] [Full Text] [Related]

  • 12. Specificity of Mycobacterium tuberculosis phenolic glycolipid (PGL-Tb1) antiserum.
    Papa F, Laszlo A, David HL.
    Ann Inst Pasteur Microbiol; 1988 Jan 03; 139(5):535-45. PubMed ID: 2472828
    [Abstract] [Full Text] [Related]

  • 13. Lack of correlation between colony morphology and lipooligosaccharide content in the Mycobacterium tuberculosis complex.
    Lemassu A, Lévy-Frébault VV, Lanéelle MA, Daffé M.
    J Gen Microbiol; 1992 Jul 03; 138(7):1535-41. PubMed ID: 1512581
    [Abstract] [Full Text] [Related]

  • 14. Total synthesis of the triglycosyl phenolic glycolipid PGL-tb1 from Mycobacterium tuberculosis.
    Barroso S, Castelli R, Baggelaar MP, Geerdink D, ter Horst B, Casas-Arce E, Overkleeft HS, van der Marel GA, Codée JD, Minnaard AJ.
    Angew Chem Int Ed Engl; 2012 Nov 19; 51(47):11774-7. PubMed ID: 23086739
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of DNA fragment patterns between the phenolic glycolipid-Tb producers and non-producers of Mycobacterium tuberculosis.
    Lee TY, Cho SN, Yoon KH, Shin JS, Kim JD.
    Yonsei Med J; 1991 Sep 19; 32(3):243-9. PubMed ID: 1664164
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the specific antigenicity of representatives of M. senegalense and related bacteria.
    Besra GS, Gurcha SS, Khoo KH, Morris HR, Dell A, Hamid ME, Minnikin DE, Goodfellow M, Brennan PJ.
    Zentralbl Bakteriol; 1994 Nov 19; 281(4):415-32. PubMed ID: 7727889
    [Abstract] [Full Text] [Related]

  • 17. Antigenicity and specificity of selected glycolipid fractions from Mycobacterium tuberculosis.
    Papa F, Cruaud P, David HL.
    Res Microbiol; 1989 Oct 19; 140(8):569-78. PubMed ID: 2516354
    [Abstract] [Full Text] [Related]

  • 18. Distribution of antibody titres against phenolic glycolipids from Mycobacterium tuberculosis in the sera from tuberculosis patients and healthy controls.
    Watanabe M, Honda I, Kawajiri K, Niinuma S, Kudoh S, Minnikin DE.
    Res Microbiol; 1995 Oct 19; 146(9):791-7. PubMed ID: 8584801
    [Abstract] [Full Text] [Related]

  • 19. Chemical synthesis and seroreactivity of a neoantigen containing the oligosaccharide hapten of the Mycobacterium tuberculosis-specific phenolic glycolipid.
    Daffe M, Cho SN, Chatterjee D, Brennan PJ.
    J Infect Dis; 1991 Jan 19; 163(1):161-8. PubMed ID: 1898609
    [Abstract] [Full Text] [Related]

  • 20. Use of the SL-IV and the PGL-Tb1 glycolipid antigens in ELISA for the diagnosis of tuberculosis in AIDS patients.
    Berlie HC, Petit JC, David HL.
    Zentralbl Bakteriol; 1991 Aug 19; 275(3):351-7. PubMed ID: 1741916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.